Try our Advanced Search for more refined results
In Re: Prempro Products et al
Case Number:
4:03-cv-01507
Court:
Nature of Suit:
Judge:
Firms
- Venable LLP
- Faegre Drinker
- Lanier Ford
- Winston & Strawn
- Dechert LLP
- Helmsing Leach
- Fuqua Campbell
- Carey Danis
- Adams & Reese
- Gary Holt & Associates
- Daniel Coker Horton & Bell
- Anderson Helgen Davis & Cefalu
- Krislov Law
- Friday Eldredge
- Germer PLLC
- Barber Law Firm PLLC
- Baker Schulze
- Pogust Goodhead
- Beirne Maynard
- Taylor King Law
- Grogan Graffam
- Bailey & Glasser
- Stueve Siegel
- Thiebaud Remington
- Stinson LLP
- Littlepage Booth
- Hausfeld LLP
- Cohen Milstein
- Page Mannino
- Bradley Arant
- Thompson Miller & Simpson
- Butler Weihmuller
- Patterson Belknap
- Dinsmore & Shohl
- TorHoerman Law
- Vedder Price
- Albright Yee
- Quattlebaum Grooms
- Robert Peirce & Associates
- Hilburn & Harper
- Bertram & Graf
- Roxborough Pomerance
- Munson Rowlett
- Macdonald Devin
- Goodell DeVries
- Williams & Connolly
- Baker Sterchi
- Pietragallo Gordon
- Mitchell Williams
- Janet Janet
- Seyfarth Shaw
- Maynard Nexsen
- Provost Umphrey
- Skadden Arps
- Thompson Hine
- Sills Cummis
- DLA Piper
- Wheeler Trigg
- Baker Donelson
- Wright Lindsey
- Nilan Johnson
Companies
- Warner Chilcott Limited
- American College of Physicians
- Novo Nordisk A S
- Fred Hutchinson Cancer Research Center
- GlaxoSmithKline Consumer Healthcare Ltd.
- Organon & Co.
- Abbott Laboratories
- Bausch Health Cos. Inc.
- Novavax Inc.
- King Pharmaceuticals Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
January 14, 2009
Wyeth, Pfizer Push To Get Prempro MDL Tossed
A group of drugmakers, including Wyeth Pharmaceuticals Inc., Bristol-Myers Squibb Co. and Pfizer Inc., struck a defiant tone Monday in a massive multidistrict litigation accusing them of advertising and selling hormone treatments that cause breast cancer, denying all allegations and asking for the case to be dismissed.
-
December 29, 2008
9 Defendants Dismissed From Prempro Suits
A federal judge has dismissed several defendants from more than 75 cases that are part of the multidistrict product liability litigation over Wyeth Pharmaceutical Inc.'s drug Prempro and related hormone-replacement drugs.
-
November 07, 2008
Wyeth, Pfizer Face More Claims In Premarin Suit
Plantiffs in the multidistrict litigation alleging that Premarin and similar estrogen hormone-replacement drugs led to their breast cancer filed a motion Thursday to add further claims against Wyeth Inc. and Pfizer Inc. to the complaint based on new scientific data previously unavailable.
-
June 10, 2008
Wyeth Calls For Ousting Of Lawyers In Prempro MDL
Wyeth Pharmaceuticals Inc. has called for the removal of two lawyers from the steering committee of plaintiffs in multidistrict litigation over its hormone pills Prempro and Premarin, accusing the pair of trying to “end-run” the proceedings by re-serving withdrawn discovery requests in a different court.
-
May 20, 2008
Wyeth Calls For End To Discovery In Prempro MDL
Wyeth Pharmaceuticals Inc. has urged a federal judge to set a deadline for generic discovery in the multidistrict proceedings over its hormone pills, saying the speedy resolution of the litigation required an end to the drawn-out pretrial phase.
-
October 12, 2007
Lawyers Want Wyeth To Hand Over Documents
Plaintiff attorneys in the multidistrict litigation alleging Prempro and Premarin caused patients to develop breast cancer are trying to get a judge to force Wyeth Pharmaceuticals Inc. to hand over correspondence with the U.S. Food and Drug Administration regarding label changes to the hormone replacement drugs.
-
August 20, 2007
Wyeth Fights Prempro Plaintiffs' Latest Discovery Bids
Wyeth Inc. has rejected a recent set of discovery requests by plaintiffs in the multidistrict litigation over Prempro, arguing that the bid for the documents is “unrealistic” and “obviously burdensome.”
-
August 13, 2007
Wyeth Wants Prempro Records Preserved
Wyeth Inc. has asked a federal judge to make sure the medical records of plaintiffs in the multidistrict litigation over Prempro are preserved, arguing that the information is “of critical importance” to plaintiffs and defendants alike.
-
August 03, 2007
Judge Limits Discovery in Prempro MDL
In the multidistrict litigation over the hormone replacement therapy Prempro, a federal judge ordered pharmaceutical giant Wyeth on Thursday to turn over all notes made by sales representatives both before and during the time plaintiffs were prescribed the medication to alleviate symptoms relating to menopause.
-
July 05, 2007
Prempro Judge OKs Case-Specific Discovery
A judge overseeing the multidistrict litigation over Wyeth's Prempro has ruled that case-specific discovery should still go forward for individual plaintiffs who allege the pharmaceutical company's hormone drug caused breast cancer.
- ← Previous
- 1
- 2
- 3
- Next →